In trading on Monday, shares of Belite Bio Inc (Symbol: BLTE) entered into oversold territory, hitting an RSI reading of 29.96, after changing hands as low as $150.14 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 39.7. A bullish investor could look at BLTE's 29.96 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of BLTE shares:
Looking at the chart above, BLTE's low point in its 52 week range is $49 per share, with $200 as the 52 week high point — that compares with a last trade of $151.14.
Project your dividend income with confidence: Income Calendar tracks your income portfolio like a personal assistant.
Find out what 9 other oversold stocks you need to know about »
Also see:
Healthcare Dividend Stock List MUC Insider Buying
Cheap Technology Stocks
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
